Prasad Adusumilli and colleagues have shown that CAR T cells that start to lose power can be revived by immunotherapy drugs given several weeks later. Mesothelioma is a rare cancer that affects the ...
Mesothelin-targeted immunotherapies offer significant market opportunities by addressing its overexpression in various cancers such as ovarian, pancreatic, and mesothelioma. Leveraging next-gen drug ...
Future Oncol. 2009;5(3):391-402. 1 Laboratory of Molecular Oncology, Clinic and Policlinic of Oncology, University Hosptial, CH-8091 Zürich, Switzerland. 2 Division of Thoracic Surgery, University ...
The MarketWatch News Department was not involved in the creation of this content. Dover, DE, Oct. 25, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Maintenance ...
Antibody targeting of epithelial carcinoma-associated fibroblast activation protein blocks cellular proliferation, migration, and invasion. Background: Malignant pleural mesothelioma (MPM) is an ...
Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression. Background: MPM is a devastating cancer with limited effective therapies. Mesothelioma tumor cells ...
Dover, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, announce that the AACR ...
Poster presented today in Boston shows direct anti-tumor activity in mesothelioma models, reduced tumor PD-L1 alongside decreased pCREB, and strong TT-4 monotherapy activity with added benefit in anti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback